A multicenter, prospective, randomized, double-blind, active-controlled trial comparing two doses of influenza vaccine in high risk cardiovascular patients (history of myocardial infarction or heart failure)
Sign UpA collection trial for subjects 18 years or older with a rheumatology condition including but not limited to rheumatoid arthritis (RA) and/or subjects with positive antinuclear antibody (ANA) test results associated with diagnosis of: lupus erythromatosus, scleroderma, Sjogren's Syndrome, polymyositis/dermatomyositis, mixed connective tissue disease, drug-induced lupus, autoimmune hepatitis, and/or juvenile arthritis.
Sign UpBI 695501 versus HUMIRA in patients with active Crohn's Disease: a randomized, double-blind, multicenter, parallel group, non-inferiority trial comparing efficacy, endoscopic improvement, sarety, and immunogenicity.
Sign UpA multicenter, randomized, double-blind, placebo-controlled induction study of the efficacy and safety of Risankizumab in subjects with moderately to severely active Crohn's Disease
Sign UpA multicenter, randomized, double-blind, placebo-controlled induction study of the efficacy and safety of Risankizumab in subjects with moderately to severely active Crohn's Disease who failed prior biologic treatment
Sign UpReal-World Perception of Tolerability And Bowel Function Effects of Fuco-N-Tetraose in IBS Patients
Sign UpThe primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carbocymaltose (FCM), relative to placebo, in the treatment of participants in heart failure with reduced ejection fraction and with iron deficiency.
Sign Up